ArticleJCO global oncology2026
Integrating Human Papillomavirus and HIV Services Into a One-Stop Breast Cancer Early Detection Clinic in Zambia.
Article in JCO global oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWomen in low- and middle-income countries face overlapping burdens of breast cancer, cervical cancer, and HIV. Fragmented service delivery contributes to delayed prevention, missed diagnoses, and inefficient use of scarce health resources. We evaluated the feasibility and acceptability of an integrated service delivery model in which HIV and human papillomavirus (HPV) testing were incorporated into an established One-Stop Breast Care Clinic at the primary care level in Zambia.
methodsBetween October 2021 and March 2022, women attending the breast clinic were recruited using convenience sampling. Before breast assessment, participants were offered HIV testing and instructed in HPV self-collection. Samples were processed onsite, in the facility's laboratory, and referrals were guided by test results. Patient satisfaction was assessed through structured questionnaires. Feasibility, acceptability, and implementation challenges were explored through semi-structured interviews with hospital administrators.
resultsAmong 180 participants (the majority <55 years), 23.3% tested positive for HPV and 18.9% for HIV; all were referred for immediate follow-up care. Breast evaluations identified benign disease in 86.7% and malignancy in 13.3%. Overall satisfaction with receiving integrated HIV and HPV services during breast evaluation was high (97.2%). Satisfaction with clinic flow was reported as satisfactory by 63.9% and highly satisfactory by 33.9% of participants. Hospital administrators highlighted improved efficiency and patient-centeredness of the integrated model. The principal barrier to sustainability was the cost of HPV testing.
conclusionIntegration of cervical cancer screening, breast cancer early detection, and HIV services into a single women-centered clinic at the primary care level is feasible, acceptable, and resource-efficient. This model aligns with global elimination and early detection targets and offers a scalable approach to strengthen women's health services in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.